-
1دورية أكاديمية
المؤلفون: Taichi Miyawaki, Hirotsugu Kenmotsu, Kosei Doshita, Hiroaki Kodama, Naoya Nishioka, Yuko Iida, Eriko Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, Shota Omori, Ryo Ko, Kazushige Wakuda, Akira Ono, Tateaki Naito, Haruyasu Murakami, Keita Mori, Hideyuki Harada, Masahiro Endo, Kazuhisa Takahashi, Toshiaki Takahashi
المصدر: Cancer Medicine, Vol 12, Iss 2, Pp 1451-1460 (2023)
مصطلحات موضوعية: clinical cancer research, immunology, lung cancer, metastasis, non‐small‐cell lung cancer, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: https://doaj.org/toc/2045-7634Test
-
2دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103038.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103038Test -
3دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103053.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_4_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103053Test -
4دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103044.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103044Test -
5دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103056.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103056Test -
6دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103041.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_3_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103041Test -
7دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103035.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Table_5_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103035Test -
8دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103062.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_1_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103062Test -
9دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103059.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Figure_2_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103059Test -
10دورية أكاديمية
المؤلفون: Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
مصطلحات موضوعية: Cancer, Immuno-oncology, Clinical Research and Trials, Lung Cancer, Clinical Trial Results, Phase II clinical trials, Immunotherapy, Checkpoint blockade, Combination immunotherapy
الإتاحة: https://doi.org/10.1158/2767-9764.25103050.v1Test
https://figshare.com/articles/journal_contribution/Supplemental_Methods_from_Phase_II_Study_of_the_Liposomal_Formulation_of_Eribulin_E7389-LF_in_Combination_with_Nivolumab_Results_from_the_Small_Cell_Lung_Cancer_Cohort/25103050Test